These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3057217)

  • 1. New pharmacological treatment of acute spinal cord trauma.
    Hall ED; Braughler JM; McCall JM
    J Neurotrauma; 1988; 5(1):81-9. PubMed ID: 3057217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemistry and pharmacology of lipid antioxidants in acute brain and spinal cord injury.
    Hall ED; Yonkers PA; Andrus PK; Cox JW; Anderson DK
    J Neurotrauma; 1992 May; 9 Suppl 2():S425-42. PubMed ID: 1613805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of effect of postinjury treatment with methylprednisolone or tirilazad mesylate on the increase in eicosanoid levels in the acutely injured cat spinal cord.
    Hall ED; Yonkers PA; Taylor BM; Sun FF
    J Neurotrauma; 1995 Jun; 12(3):245-56. PubMed ID: 7473799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of lipid peroxidation in post-traumatic spinal cord degeneration: a review.
    Hall ED; Braughler JM
    Cent Nerv Syst Trauma; 1986; 3(4):281-94. PubMed ID: 3555850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidant effects in brain and spinal cord injury.
    Hall ED; Braughler JM; McCall JM
    J Neurotrauma; 1992 Mar; 9 Suppl 1():S165-72. PubMed ID: 1588607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug development in spinal cord injury: what is the FDA looking for?
    Hall ED
    J Rehabil Res Dev; 2003; 40(4 Suppl 1):81-91. PubMed ID: 15077652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free radicals in CNS injury.
    Hall ED; Braughler JM
    Res Publ Assoc Res Nerv Ment Dis; 1993; 71():81-105. PubMed ID: 8380240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective actions of glucocorticoid and nonglucocorticoid steroids in acute neuronal injury.
    Hall ED
    Cell Mol Neurobiol; 1993 Aug; 13(4):415-32. PubMed ID: 8252611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of spinal cord injury. Current and future therapies.
    Hall ED
    Minerva Anestesiol; 1989 Mar; 55(3):63-6. PubMed ID: 2693998
    [No Abstract]   [Full Text] [Related]  

  • 10. The neuroprotective pharmacology of methylprednisolone.
    Hall ED
    J Neurosurg; 1992 Jan; 76(1):13-22. PubMed ID: 1727150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid antioxidants in acute central nervous system injury.
    Hall ED
    Ann Emerg Med; 1993 Jun; 22(6):1022-7. PubMed ID: 8503522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological treatment of acute spinal cord injury: how do we build on past success?
    Hall ED
    J Spinal Cord Med; 2001; 24(3):142-6. PubMed ID: 11585231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of combined treatment with melatonin and methylprednisolone on neurological recovery after experimental spinal cord injury.
    Cayli SR; Kocak A; Yilmaz U; Tekiner A; Erbil M; Ozturk C; Batcioglu K; Yologlu S
    Eur Spine J; 2004 Dec; 13(8):724-32. PubMed ID: 15232723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between attenuation of posttraumatic spinal cord ischemia and preservation of tissue vitamin E by the 21-aminosteroid U74006F: evidence for an in vivo antioxidant mechanism.
    Hall ED; Yonkers PA; Horan KL; Braughler JM
    J Neurotrauma; 1989; 6(3):169-76. PubMed ID: 2810381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the 21-aminosteroid U74006F on posttraumatic spinal cord ischemia in cats.
    Hall ED
    J Neurosurg; 1988 Mar; 68(3):462-5. PubMed ID: 3343617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of treatment with U-74006F on neurological outcome following experimental spinal cord injury.
    Anderson DK; Braughler JM; Hall ED; Waters TR; McCall JM; Means ED
    J Neurosurg; 1988 Oct; 69(4):562-7. PubMed ID: 3418389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic strategies in the treatment of experimental spinal cord injury.
    Nockels R; Young W
    J Neurotrauma; 1992 Mar; 9 Suppl 1():S211-7. PubMed ID: 1588610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of the lazaroids (21-aminosteroids) in acute central nervous system trauma, ischemia and subarachnoid hemorrhage.
    Hall ED; McCall JM; Means ED
    Adv Pharmacol; 1994; 28():221-68. PubMed ID: 8080818
    [No Abstract]   [Full Text] [Related]  

  • 19. Glucocorticoid mechanisms in acute spinal cord injury: a review and therapeutic rationale.
    Hall ED; Braughler JM
    Surg Neurol; 1982 Nov; 18(5):320-7. PubMed ID: 7179094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking weight-induced spinal cord injury in rats: therapeutic effect of the 21-aminosteroid U74006F.
    Holtz A; Gerdin B
    J Neurotrauma; 1991; 8(4):239-45. PubMed ID: 1803032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.